Schwartzberg, L., Barbour, S. Y., Morrow, G. R., Ballinari, G., Thorn, M. D., & Cox, D. (2013). Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV). Springer Berlin Heidelberg.
Chicago Style CitationSchwartzberg, Lee, Sally Y. Barbour, Gary R. Morrow, Gianluca Ballinari, Michael D. Thorn, i David Cox. Pooled Analysis of Phase III Clinical Studies of Palonosetron Versus Ondansetron, Dolasetron, and Granisetron in the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV). Springer Berlin Heidelberg, 2013.
Cita MLASchwartzberg, Lee, et al. Pooled Analysis of Phase III Clinical Studies of Palonosetron Versus Ondansetron, Dolasetron, and Granisetron in the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV). Springer Berlin Heidelberg, 2013.